These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1679770)

  • 1. Instrumental evidence that age increases motor instability in neuroleptic-treated patients.
    Caligiuri MP; Lohr JB; Jeste DV
    J Gerontol; 1991 Sep; 46(5):B197-200. PubMed ID: 1679770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand.
    Caligiuri MP; Lohr JB
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):395-8. PubMed ID: 1983784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetrical hand force persistence and neuroleptic treatment in schizophrenia.
    Purdon SE; Woodward ND; Flor-Henry P
    J Int Neuropsychol Soc; 2001 Jul; 7(5):606-14. PubMed ID: 11459112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients.
    Caligiuri MP; Lohr JB
    Biol Psychiatry; 1994 Jan; 35(2):104-11. PubMed ID: 7909452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapyramidal motor abnormalities associated with late-life psychosis.
    Caligiuri MP; Lohr JB; Panton D; Harris MJ
    Schizophr Bull; 1993; 19(4):747-54. PubMed ID: 7905662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetry of neuroleptic-induced rigidity: development of quantitative methods and clinical correlates.
    Caligiuri MP; Bracha HS; Lohr JB
    Psychiatry Res; 1989 Dec; 30(3):275-84. PubMed ID: 2575771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic dose reduction in older psychotic patients.
    Harris MJ; Heaton RK; Schalz A; Bailey A; Patterson TL
    Schizophr Res; 1997 Oct; 27(2-3):241-8. PubMed ID: 9416653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of activation procedures on neuroleptic-induced akathisia.
    Fleischhacker WW; Miller CH; Barnas C; Bergmann K; Perovich R; Alvir JM; Lieberman JA; Kane JM
    Br J Psychiatry; 1993 Dec; 163():781-4. PubMed ID: 7905775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of relapse following neuroleptic withdrawal.
    Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
    Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dosage of neuroleptics (author's transl)].
    Haase HJ
    MMW Munch Med Wochenschr; 1980 Dec; 122(50):1808-13. PubMed ID: 6110184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
    Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
    Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
    Moritz S; Krausz M; Gottwalz E; Andresen B
    Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related differences in inter-digit coupling during finger pinching.
    Keogh J; Morrison S; Barrett R
    Eur J Appl Physiol; 2006 May; 97(1):76-88. PubMed ID: 16496196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies.
    Goldberg TE; Weinberger DR
    J Clin Psychiatry; 1996; 57 Suppl 9():62-5. PubMed ID: 8823353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients.
    Carman JS; Bigelow LB; Wyatt RJ
    J Clin Psychiatry; 1981 Mar; 42(3):124-8. PubMed ID: 6110654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.
    Gupta S; Andreasen NC; Arndt S; Flaum M; Schultz SK; Hubbard WC; Smith M
    Am J Psychiatry; 1995 Feb; 152(2):191-6. PubMed ID: 7840351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of antipsychotic effects of neuroleptic drugs.
    Keck PE; Cohen BM; Baldessarini RJ; McElroy SL
    Am J Psychiatry; 1989 Oct; 146(10):1289-92. PubMed ID: 2571305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study.
    Mann K; Bartels M; Gärtner HJ; Schied HW; Wagner W; Heimann H
    Pharmacopsychiatry; 1987 Jul; 20(4):155-9. PubMed ID: 2886997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.